Exploiting Macropinocytosis Drives Redox Vulnerability to Preferentially Target Drug-Resistant Cancer.

Lim JH, Kim Y, Kim SM, Choi KH, Park J, Yoon H, Park K, Park KC, Hur C

Open source

DOI
10.1021/acsnano.6c04236
Published
2026 Jul 28
Container
ACS nano
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsnano.6c04236,
  title = {Exploiting Macropinocytosis Drives Redox Vulnerability to Preferentially Target Drug-Resistant Cancer.},
  author = {Lim JH and Kim Y and Kim SM and Choi KH and Park J and Yoon H and Park K and Park KC and Hur C},
  year = {2026},
  journal = {ACS nano},
  doi = {10.1021/acsnano.6c04236},
  url = {https://doi.org/10.1021/acsnano.6c04236}
}

RIS

TY  - JOUR
TI  - Exploiting Macropinocytosis Drives Redox Vulnerability to Preferentially Target Drug-Resistant Cancer.
AU  - Lim JH
AU  - Kim Y
AU  - Kim SM
AU  - Choi KH
AU  - Park J
AU  - Yoon H
AU  - Park K
AU  - Park KC
AU  - Hur C
PY  - 2026
JO  - ACS nano
DO  - 10.1021/acsnano.6c04236
UR  - https://doi.org/10.1021/acsnano.6c04236
ER  - 

APA

JH, L., Y, K., SM, K., KH, C., J, P., H, Y., K, P., KC, P., & C, H. (2026). Exploiting Macropinocytosis Drives Redox Vulnerability to Preferentially Target Drug-Resistant Cancer.. ACS nano. https://doi.org/10.1021/acsnano.6c04236

Source records